Podcasts about healthtech

Dr. Jason Wersland turned a 3 a.m. garage experiment into the number one percussive therapy brand in the world, with more than 6.5 million Theragun massage devices sold. In this episode, he breaks down the unglamorous eight-year grind behind that overnight success: five prototypes, three bad partners, and a one-to-one credibility-building strategy that eventually landed him in Cristiano Ronaldo''s training room. For more on Therabody and show notes click here   Subscribe and watch Shopify Masters on YouTube!Sign up for your FREE Shopify Trial here.

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

Jessica from SomX chatted through all the best news from this week with Heather Cook, Fiona McCormick and Toby Croft.

In this episode, I'm joined by Max, co-founder of Superpower, a longevity and preventive health company based in San Francisco. Max shares his unconventional journey from a curious, entrepreneurial kid in Sydney to building one of health tech's most ambitious startups — all without a clinical background. He offers a refreshingly direct perspective on why clinicians are uniquely positioned to drive change in healthcare, why sunk cost is a trap, and why the best time to make your move is now. If you're a healthcare professional thinking about stepping into health tech, this episode will challenge the way you think about your career.Quotes:"Health professionals are some of the best placed to actually create change in health." - Max"Servicing a system allows you to impact maybe a few hundred or thousand people. Building a system ideally gets to the millions over time." - Max"The fastest path between A and Z is not to go through B, C, D — just do the thing." - Max"Being willing to be dumb is almost a prerequisite to being smart." - Max"If you're trying to do something in a new way, it's very hard to do that from the model of thinking that created the existing way." - MaxShow Notes:Why clinicians have an unfair advantage when building in health techHow to stop letting sunk cost hold you back from a career pivotThe difference between servicing the healthcare system and building itWhy the "one day I'll do this" mindset is keeping you stuckHow an outsider perspective can be the most powerful tool for reinventing healthcareLinks: https://www.matchday.health/ https://superpower.com/ https://www.linkedin.com/in/maxmarchione/

This episode of Quality Matters examines the growing role of digital wellness and chronic condition management programs and the challenge of measuring what truly matters. Host Rachel Harrington is joined by Peter Robertson of the Purchasing Business Group on Health and California Quality Collaborative and Kevin Masci of Omada Health to discuss how digital health solutions can help address rising healthcare costs, workforce shortages and fragmented care experiences. Peter and Kevin explain why meaningful engagement goes far beyond app downloads and login counts. Instead, successful programs focus on sustained participation, patient-centered goal setting, integration with primary care and measurable improvements in health outcomes. The conversation explores how employers, health plans and providers are evaluating digital solutions through clinical outcomes, patient-reported outcomes, utilization measures and value-based contracting arrangements. The guests also discuss one of the most important challenges facing digital health: trust. Privacy, transparency, data security and clear communication about how patient data is collected and used all play critical roles in long-term adoption. The episode concludes with a Patient Voice segment featuring Brandee Hicks, who shares her firsthand experiences using digital health tools, highlighting both the convenience they offer and the ongoing challenges around interoperability, digital literacy and maintaining support after programs end.     Highlights Beyond Logins and Clicks Meaningful engagement isn't about how often patients open an app. It's about helping people achieve their health goals through sustained participation and measurable outcomes. Measuring What Matters Guests discuss the growing use of clinical outcomes, patient-reported outcomes, utilization data and value-based contracting to assess digital health program performance. Trust Is Essential Digital health solutions must address concerns around privacy, transparency, data security and how patient information is stored and shared. The Patient Perspective Brandee Hicks shares how digital tools can improve organization, access and self-management while also revealing gaps in continuity, support and interoperability. Looking Ahead The future of digital health depends on better integration with primary care, more personalized engagement strategies and stronger measurement frameworks that prioritize patient outcomes.     Key Quote: "If we're really serious about improving health outcomes, we have to move beyond measuring clicks and logins. The real question is whether people are achieving meaningful progress toward their health goals—and whether these programs are creating lasting value for patients, providers and purchasers alike." — Kevin Masci     Time Stamps: (02:20) Meet Peter Robertson (03:45) Meet Kevin Masci (05:53) Why Digital Solutions Matter (10:01) Care Coordination, Not Care Fragmentation (11:52) Defining Meaningful Patient Engagement (15:07) Why Consistent Measurement Matters (18:32) Measuring Outcomes in Value-Based Contracts (21:12) Data Stratification, Risk Adjustment and Performance Guarantees (27:22) Privacy, Trust and Transparency in Digital Health (30:44) The Future of Digital Wellness and Chronic Care Management (35:08) Patient Voice: Brandee Hicks (40:25) Patient Challenges, Access and Continuity of Care (45:23) Key Takeaways and Closing Thoughts     Dive Deeper: Connect with Peter Robertson Connect with Kevin Masci Connect with Brandee Hicks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What does it really take to thrive as a first-time fund manager in today's challenging investment landscape, especially when you're building a venture fund from scratch while championing diversity and innovation? This episode delves into the real experiences behind the headlines, inviting listeners to consider the often unseen hurdles and triumphs that define entrepreneurial journeys. Our guest, Laurel Mintz, is the founder of Fabric VC—a new venture capital fund spun out of her extensive 17-year run as the leader of a successful marketing agency. With a background that includes corporate M&A law, entrepreneurship, and marketing, Laurel Mintz brings a unique and practical perspective to the venture capital world. Her approach blends deep sector knowledge with a commitment to supporting underrepresented founders and championing women's health, fintech, and consumer tech sectors. In this update, listeners get an inside look at the nuts and bolts of raising and deploying Fabric VC's first fund—just under $8 million, already largely deployed across 23 portfolio companies. Laurel Mintz shares candid insights on the emotional rollercoaster of fundraising, the critical importance of diversity, and the creative approaches to supporting women-led companies, such as accepting investments via donor-advised funds and retirement accounts. This episode is a must-listen for aspiring investors, founders, or anyone interested in how real change is being made within venture capital. It's raw, motivating, and packed with unfiltered advice on how to show up, take risks, and put capital to work for the next generation.   To get the latest from Laurel Mintz, you can follow her below! LinkedIn - https://www.linkedin.com/in/laurel-mintz/ https://www.fabricvc.com/ Laurel's first appearance on The Angel Next Door    Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing! Website: www.marciadawood.com Learn more about the documentary Show Her the Money: www.showherthemoneymovie.com And don't forget to follow us wherever you are! Apple Podcasts: https://pod.link/1586445642.apple Spotify: https://pod.link/1586445642.spotify LinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/ Instagram: https://www.instagram.com/theangelnextdoorpodcast/ TikTok: https://www.tiktok.com/@marciadawood

What can the rest of the world learn from one of Europe's most impressive digital health ecosystems? This week on Pulse: Amplify, Louise and George sit down with Inma Rodríguez, Market Intelligence Manager at ACCIÓ (Catalonia Trade & Investment), who led the Digital Health in Catalonia Report 2026 — a rare regional analysis that benchmarks Catalonia against the US, Asia and the rest of Europe.Inma unpacks where Europe really sits in the global market (and whether it's keeping pace or falling behind), why digital health growth is settling into a more mature ~5% a year, and whether Europe's focus on regulation, interoperability and data governance is a brake or a long-term advantage. She explains how Catalonia became the 4th region in the world for foreign health-innovation investment, the role anchor investors like AstraZeneca play, and why 65% of the region's digital health companies are building with AI. The conversation also turns to the honest gap revealed in Catalonia's hospital survey — strong ambition, moderate maturity — and the cultural, budget and patient-habit barriers slowing real-world implementation. Inma closes with the seven trends shaping 2026, why AI, personalised medicine and health data spaces top her list, and the 2030 headline she most wants to see.A data-rich conversation for anyone who wants evidence, not hype, about where digital health is heading.Stryker Vocera's Initial Delays Diagnosis Quiz LinkCheck out the ACCIO Report hereConnect with Inma on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

The following article of the AI Cloud & Data industry is: “Latin America's Healthtech Revolution Is Underway” by Guillaume Corpart, Founder & CEO, Global Health Intelligence.

Episode 78 - Demi Radeva is CEO and Chief Strategist at Akros Advisory, where she helps digital health companies bring new products to market and accelerate growth.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Autonomous vehicles may be the closest real-world example of AI operating in life-and-death situations at scale. Justin Norden believes healthcare has a lot to learn from how that industry approached safety, testing, adoption, and trust. This week, Michael and Halle sit down with the founder and CEO of Qualified Health, fresh off the company's $125 million Series B, to discuss why healthcare organizations need to think differently about deploying AI. Justin shares how his experience at Stanford, Apple, Waymo, and in healthcare investing shaped his view that health systems need AI infrastructure, governance, and workforce buy-in, not just another point solution.We cover:What healthcare can learn from Waymo's approach to safe AI deploymentWhat founders need to understand about building around EpicWhy health systems need to treat AI as a CEO-level priority, not an innovation projectHow Qualified Health is helping systems deploy, monitor, and measure AI workflowsWhy governance, safety, and ROI matter as much as model performanceWhy clinicians are right to be skeptical about AI liabilityAbout our guest:Justin Norden, MD is Co-Founder and CEO of Qualified Health building the trusted platform for health system AI. Additionally, he has been an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research where his research and teaching focused on AI in medicine and digital health where he founded and still teaches courses on digital health and generative AI in medicine. Previously, Dr. Norden was Co-Founder and CEO of Trustworthy AI, a company focused on algorithm safety and trust, which was acquired by Waymo (Google Self-Driving). He was a Partner at GSR Ventures leading investments in healthcare and AI, worked on the healthcare team at Apple, and helped start the Stanford Center for Digital Health. Dr. Justin Norden received an MD and MBA from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Computer Science from Carleton College.—

Quiet Courage of the CMO There is a version of the marketing leader's job that looks great on a slide deck, and then there is the real thing. On this episode, we wanted to get at the real thing. Host Adam Turinas sat down with two marketing leaders who are currently in the middle of major company transformations, Erik Johnson, VP of Marketing at Harmony Healthcare IT, and Steffany Whiting, EVP of Marketing at iMethods. They are talking rebrands, ABM programs built from scratch, website overhauls, and bold calls about where to focus and where to pull back. The stakes are real for both of them. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Kara Egan, founder and CEO of Teal Health.Teal Health is the company behind the first FDA-authorized at-home cervical cancer screening wand.Before founding Teal, Kara worked in healthcare and software investing at .406 Ventures and Emergence Capital, and held product and marketing roles at Zendesk and Stitch Labs.  In this interview, Kara discusses building support and follow-up into at-home screening, how Teal expanded its comparative clinical study to support broader market adoption, and how healthcare incentives, reimbursement, and institutional trust shape new care models.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kara Egan, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:49) - Kara's background in health technology investing and software that shaped Teal's consumer-first approach (05:14) - How Teal turned the traditional Pap smear into the first FDA-authorized at-home screening product (07:30) - Turning at-home testing, telehealth, and clinician follow-up into a single care experience (13:48) - Raising Teal's first $1M with mockups and consumer-grade design (22:17) - Teal's comparative study that matched physician-collected screening with 96% sensitivity (23:40) - How asking women what they actually wanted changed Teal's view of the market opportunity (32:05) - “Take off the healthcare hat” — Kara's framework for fundraising, incentives, and commercialization (41:48) - What investors actually care about beyond the company's mission

Jessica from SomX chatted through all the best news from this week with Coulter Partners' Ian Coyne.

In this Hot Topics episode, Louise joins from London after an unexpected encounter with the UK healthcare system, while George reports back from the Digital Health Festival.The pair discuss New Zealand's $450 million digital health and cyber investment, a major new King's College London study showing one in seven people are already using AI instead of seeing a doctor, Demis Hassabis' bold prediction that we're entering the "foothills of the singularity", and two emerging AI approaches aimed at predicting serious disease before symptoms appear.Plus, a shout-out to Australian health tech company ThinkMD.ai for winning international recognition at the World Health Assembly.Topics covered:New Zealand's renewed investment in digital health and cyber security Why patients are increasingly turning to AI before healthcare professionals Public trust, regulation and the future of clinical AI Google's vision for AI-driven scientific discovery Predicting liver disease years earlier using historical pathology data Longevity science and AI-powered disease prediction What healthcare needs to do to keep pace with accelerating technological changeResources:Stryker Vocera's Initial Delays Diagnosis Quiz LinkDigital Health Workforce Census (opens 1 May, ANZ) LinkHospital Sant Pau, Barcelona LinkThe Use of AI in UK Healthcare Report, King's College London LinkWHO endorses precision medicine resolution LinkCongrats to ThinkMD.ai and Dr Jackie Rabec – Pulse+IT LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Acteur majeur de la e-santé en France, Lifen développe des solutions d'interopérabilité et d'intelligence artificielle pour fluidifier le partage et l'exploitation des données médicales au service des soignants et de la recherche clinique. Dans cet épisode, Raphaëlle Leprince défend une fonction RH résolument tournée vers le business, l'innovation et l'accompagnement du changement. Après un parcours entre grands groupes et startups, elle accompagne aujourd'hui la croissance d'une HealthTech où l'IA transforme les métiers et les compétences. Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

MTANZ chief executive Cushla Smyth discusses the themes and highlights of the MTANZ conference this June 29-30 in Auckland including;-       How the new medical device procurement system is progressing-       The Medical Products Bill and potential impact of political shifts on health tech regulation-       Practical insights on integrating AI tools in healthcare-       The synergy between research, startups, and established manufacturers at HealthTech Week Listen to hear how regulation, innovation, and collaborative action are shaping NZ's medtech landscape and register to attend the conference later this month.

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

How to Build a Marketing Team That People Don't Want to Leave On this episode host Adam Turinas sits down with Larry Kaiser, Chief Marketing Officer at Optimum Healthcare IT, for a candid conversation about what it really takes to build a marketing team that lasts. Larry has spent nearly a decade growing the marketing function at Optimum from a logo and an outdated Drupal website into a tight, high-performing team. The lessons he has picked up along the way are ones that any marketing leader in healthtech will recognize. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Karthik Ganesh, CEO of OnMed.OnMed is the healthcare technology company behind OnMed CareStation, a “Clinic-in-a-Box” designed to expand access to primary and urgent care. Before OnMed, Karthik served as CEO of EmpiRx Health, leading the company through rapid growth and a successful private equity transaction in 2021. Throughout his career, he's held leadership roles at QualCare, CareAllies, and Aetna, and advised healthcare organizations through Deloitte and EY.In this interview, Karthik discusses why hybrid care models still require a human touch, how enterprise healthcare buyers evaluate value propositions differently, why brand and culture should shape execution early, and how operating under constraints can sharpen innovation.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Karthik Ganesh, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - Karthik's obsession with healthcare access, and the “broken doorway” problem behind OnMed (05:51) - How OnMed combines telemedicine and brick-and-mortar care into a “Clinic in a Box” (09:04) - The OnMed metrics that surprised Karthik most, including a 37% patient return rate, and the reasons behind the company's success (09:22) - What OnMed designed differently after realizing that patients approach healthcare with their guard up (15:27) - The pitfalls of B2C healthcare and how OnMed was built as a B2B company by intention (22:01) - How Karthik reshaped OnMed around clarity, structure, and high performers (30:23) - What “brand” actually means to Karthik (39:37) - How OnMed tailored its value proposition for payers, providers, employers, and universities (45:45) - Karthik's fundraising philosophy: constraints keep companies inventive

There is a version of the marketing leader's job that looks great on a slide deck, and then there is the real thing. In this episode, I wanted to get at the real thing.I sat down with two marketing leaders who are currently in the middle of major company transformations, Erik Johnson, VP of Marketing at Harmony Healthcare IT, and Steffany Whiting, EVP of Marketing at iMethods. We are talking rebrands, ABM programs built from scratch, website overhauls, and bold calls about where to focus and where to pull back. The stakes are real for both of them.What I really wanted to explore was the human side of leading marketing at this level. The doubt. The pressure. The moments of second-guessing when you have convinced leadership to make a big bet, and you start wondering whether you went too far. What came out of this conversation was candid in a way I did not fully anticipate. Erik and Steff talked openly about how they build alignment before launching major initiatives, how they manage the ongoing pressure to show ROI from programs that take time to prove out, and what they do when the inner voice starts asking hard questions. They also went back into their careers to talk about the moments they were genuinely in over their heads, and what those experiences taught them.If you are a healthtech marketing leader carrying the weight of a big program right now, this episode is for you. And honestly, if you are early in your career and wondering what it actually looks like to lead at this level, this is worth your time too.Key Topics Covered“(00:00:00)” - Introduction"(00:01:00)" - What It Really Means to Lead Marketing in Healthtech"(00:03:00)" - Guest Introductions: Steffany Whiting and Erik Johnson"(00:06:00)" - Risk-Taking in a Fast-Moving Environment"(00:08:00)" - iMethods' Bold Call to Step Back from Events in 2026"(00:10:00)" - Building and Sustaining ABM Programs: The Long Game"(00:16:00)" - Why ABM Is Poorly Named (and What It Actually Is)"(00:20:00)" - Leading a Rebrand: Conviction, Expectation-Setting, and Founder Dynamics"(00:23:00)" - The Website Overhaul at iMethods"(00:25:00)" - Moments of Self-Doubt and What Brings You Back"(00:28:00)" - Have You Ever Genuinely Wondered If You Were the Right Person for the Job?"(00:32:00)" - Where Resilience Comes From in Healthcare Marketing"(00:34:00)" - Advice to a Younger Self"(00:39:00)" - Five Key Lessons From the ConversationIf you are interested in discussing this or any other topic, let's have a chat.  Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.Follow me on LinkedIn.Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.

Behavioral Health is Under Pressure, and Healthtech is Here to Help On this episode of In Practice, Dr. Robert Murry, chief medical officer at NextGen Healthcare, is joined by Javier Favela, vice president of market and segment strategy at NextGen Healthcare, and Erin Paige, solutions engineer at NextGen Healthcare and a licensed associate counselor, for a timely conversation on the pressures facing behavioral health organizations today. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Health Affairs Publishing's Jeff Byers welcomes Andrew Rundle of the Columbia University Mailman School of Public Health to the pod to discuss his recent Forefront article about Medicare's upcoming ACCESS model and its potential to expand digital health for chronic disease management. They discuss why the program could spur rapid growth in health tech while highlighting key challenges, including serving an older population with varying degrees of digital literacy and adapting to a new, evidence-driven marketplace. Related Links:The ACCESS Model May Set Off A Health Tech Gold Rush, But New Markets Bring Serious Obstacles (Health Affairs Forefront)A deeper dive into the ACCESS Model—Who's participating, potential headwinds and how it could spur health plan adoption (Fierce Healthcare)ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model (CMS)ACCESS Model Accepted Applicants (CMS)Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. Dr Nick (van Terheyden) brings his trademark frankness to Pulse, unpacking AI panic, broken healthcare business models, clinician workflow, digital transformation myths, and the technologies people are still underestimating. A fast-moving discussion spanning evidence, empathy, innovation, and the future of care.Nick's recent article ‘Your fear of AI isn't rational, it's prehistoric LinkConnect with Dr Nick on LinkedInStryker Vocera's Initial Delays Diagnosis Quiz LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

India's ₹1.5 Lakh Crore DARPA Moment For Deep Tech could reshape India's R&D, startup funding and innovation economy. In this special episode of The Core Report, Govindraj Ethiraj speaks with Dr. Shivkumar Kalyanaraman, CEO of ANRF, on India's biggest push yet to fund deep tech, research and development, and future technologies.Dr. Kalyanaraman explains how the Anusandhan National Research Foundation, the RDI scheme, TDB and BIRAC are backing companies and projects with patient capital, long term debt, convertibles and blended finance.CHAPTERS:(00:00) Introduction (02:00) India's New Push to Fund Research and Deep Tech(02:30) How the First RDI Projects Were Selected(04:10) From 6G to Space Tech: What the Fund Is Backing(06:02) Ticket Sizes, Loans, and Convertible Funding(06:30) How ANRF Compares With DARPA(07:32) How ANRF Is Changing India's Research Funding Model(08:26) Grants, Translation, and Private Sector Scale-Up(10:36) How ANRF Is Choosing Themes and Projects(12:15) Monitoring, Mentoring, and Measuring Research Outcomes(13:46) Lessons From His Experience in IBM and Microsoft(15:30) Where AI Fits Into India's R&D Funding Push(16:50) Standout Areas: Space Tech, Health Tech, Drones, and AI(18:27) How Big and Small Companies Can Access RDI Funding(20:16) Strengthening Academic Research and Translation(21:54) What Patient Capital Really Means(23:50) Funding Energy Transition and Critical Raw Materials(25:24) The Scientific Problems India Should Solve Next(27:23) India's Unfinished Agenda for Scientific ExcellenceRegister for our event on June 2nd⁠Check out our Live Earnings tracker: ⁠https://earnings.thecore.in/⁠For more of our coverage check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠thecore.in⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to our Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow us on:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |⁠⁠⁠⁠ ⁠⁠Youtube⁠⁠⁠⁠⁠⁠

Doctors are using ChatGPT in clinic right now — and some of them don't care about privacy. Three operators on what that means for healthcare AI. Recorded live at health.tech in Basel, this panel from Faces of Digital Health unpacks the convergence reshaping clinical software: ambient AI scribes, agentic AI in healthcare, on-device LLMs, and the regulatory drag (MDR, EU AI Act, EHDS) that is widening the gap between what clinicians actually use and what hospitals are allowed to buy. Host Tjaša Zajc is joined by: Jonathan Bringas — CEO & Founder, Lapsi Health (Kaiku: FDA-cleared AI stethoscope, ambient scribe and clinical assistant in one device) Blaž Triglav — CEO, Mediately (drug information platform, 1M+ HCPs across Europe) Amanda Herbrand — Clinical data modelling consultant, formerly University Hospital Basel What the conversation covers: — Why EHR data fragmentation is the precondition AI hasn't solved — Shadow AI: why clinicians trust ChatGPT more than enterprise tools (and the agency hypothesis behind it) — The convergence of stethoscopes, scribes, drug information and decision support into one workflow layer — ROI in healthcare AI: financial, time, clinical accuracy — and Herbrand's fourth dimension, user satisfaction — "Doctors were the original vibe coders": the 2,000 Excel spreadsheets running European hospitals — Why FDA-cleared beats MDR in 2026 sales cycles, and what Chile's regulatory minimalism tells us — The asymmetry that will break European medtech: applicants using AI to build, regulators forbidden from using AI to assess — On-device AI, ambient computing, AGI in clinical workflows — and the de-skilling risk no one wants to discuss ⏱ Chapters 00:00 — Opening: AI agents, vibe coding, and what doctors actually want 01:30 — Data fragmentation: the precondition AI hasn't solved (Amanda Herbrand) 02:30 — Keiku: collapsing stethoscope, scribe and assistant into one device 05:15 — The convergence reshaping healthcare AI — and the shadow AI in clinic 07:30 — Why doctors trust ChatGPT more than enterprise tools: the agency hypothesis 10:30 — ROI: financial, time, clinical accuracy — and Herbrand's fourth dimension 15:30 — Choosing solutions: modular requirements and FDA-cleared moats 19:30 — EHDS and the missing connector in European standardisation 21:00 — "Doctors were the original vibe coders": the 2,000 spreadsheet problem 24:30 — The two-speed world: regulated medicine vs the Wild West 28:00 — Why Chile's regulatory minimalism beats Europe's MDR 30:30 — Agentic AI vs regulators: the asymmetry that will break European medtech 33:30 — On-device AI, AGI, and the deskilling no one wants to discuss

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman, founder and CEO of Clairity.Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram.A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imaging Specialist at Massachusetts General Brigham (on leave). She holds an MD and PhD from Yale and was named to Forbes' 50 Over 50 Innovators and TIME 100 World's Most Influential Leaders in Health.In this interview, Connie discusses her experience translating academic research into a commercially viable startup, the massive undertaking of generating clinical evidence when you're creating a new category, and how Clairity is approaching adoption on two fronts: fitting into physician workflows and building access pathways for patients.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Connie Lehman, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - The broken screening paradigm Connie saw in clinic — and the gap that became Clairity (05:09) - How Clairity rolls the clock back from detection to predicting risk in healthy women (07:31) - Why "more data is better" turned out to be wrong and how that shaped Clairity's product scope (21:57) - How physicians can translate grant-generating discipline into building a company (24:56) - What 18 months of pre-sub meetings revealed about navigating a de novo pathway (26:49) - Why Clairity validated its technology in over 250,000 mammograms when FDA required far less (34:43) - How Connie flipped the natural question from "how can doctors offer this?" to "how can women access it?" (43:47) - How relationships, not pitches, drove Clairity's $43M Series B

How much business are you losing simply because you're not staying in consistent contact with your audience? Most companies don't have a sales problem—they have a follow-up problem. And follow-up isn't about chasing people…it's about staying top of mind with value, relevance, and consistency. That's why my interview with Smita Wadhawan, CMO of Constant Contact, on the THINK Business – What Are You Good At? series hit on a hard truth—consistency is the new marketing advantage. Here are 5 takeaways that stood out: ✅ Mindshare → Market Share People can't buy from you if they forget you exist. Marketing isn't optional—it's oxygen. ✅ Consistency builds trust Trust isn't built in a moment—it's built in the follow-up moments people rarely do. ✅ Simple wins Customers don't want clever. They want clear. They want fast. They want relevant. ✅ Start now—then scale Stop overthinking platforms, funnels, or brand perfection. Start small. Ship. Learn. Improve. ✅ AI is here to help, not replace Use AI to automate repetitive work—so you can stay human where it matters most.   Smita Wadhawan Verma Global Chief Marketing Officer | Top 50 CMO | PayPal | Intuit | GoDaddy | Visa | SaaS | HealthTech | FinTech Award-winning Chief Marketing Officer with experience at GoDaddy, PayPal, Intuit, VISA, and SimplePractice — across SMB/consumer, SaaS, HealthTech, and FinTech. Global teams and global leadership at EcoVadis. Scaled and led businesses from a mid-size company to a $32B established brand, with budgets up to $175M. Expertise in growth marketing, product marketing, B2B and B2C marketing, lifecycle marketing, PR and comms. Smita has built and led teams of 150+ people in highly matrixed, cross-functional organizations across the US, Europe, Africa, Japan and India. She has partnered with top agencies like Koto, Instrument, Razorfish, TBWA, Highwire PR — and managed award-winning internal creative teams. Under Smita's leadership, her teams have won Digiday Awards and several Webby Award nominations. Smita is well known as a culture champion and recognized as a highly influential and inclusive C-Suite leader who can inspire teams to deliver outstanding results. Recognized as a 2024 Top 50 CMO in the US. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience Website: https://jondwoskin.comLinkedIn: https://www.linkedin.com/in/jondwoskin Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Jeff Gunsberg:Website: https://title-connect.com Connect with Smita Wadhawan:LinkedIn: https://www.linkedin.com/in/smitawadhawan/ *E - explicit language may be used in this podcast.

Most careers don't follow a straight line. But few require starting over in full view of the public.This week, Halle sits down with Lance Armstrong to discuss how he rebuilt his life and career after multiple turning points, including surviving advanced cancer, and how those experiences shaped his perspective on health, performance, and reinvention. Now, through his venture firm Next Ventures, he backs companies focused on what they call “whole person health” — spanning prevention, wellness, diagnostics, longevity, and healthcare outside the traditional system.We cover:Why he chose to become a VC, and what he likes (and dislikes) about the jobHow his experience as a patient shapes how he evaluates companiesWhy preventive care is growing outside the traditional healthcare systemWhat he looks for in founders building across the care continuumWhat it takes to rebuild trust and start overAbout our guest:Lance Armstrong is a former professional cyclist, entrepreneur, and investor. After surviving advanced testicular cancer, he founded Livestrong, helping raise more than $500 million to support cancer patients and survivors worldwide. In 2019, he co-founded Next Ventures, a venture capital firm focused on health, wellness, and consumer brands, with investments including Oura, Cofertility, Pair Team, and SteadyMD. Prior to Next Ventures, he was an active angel investor in companies such as Uber, DocuSign, and Athletic Brewing.—

A Practical Guide to Intent-Driven ABM and AI in Healthtech This episode is the final installment in a three-part miniseries on ABM and go-to-market strategy, and it is extremely practical. Host Adam Turinas is joined by guest Rehan Mirza, Chief Growth Officer at Verifiable, a credentialing automation platform that has lived through every stage of the ABM journey, from cold outbound blasting to sophisticated, intent-driven orchestration across a complex enterprise sales motion. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

From WEDI's Spring Conference, Amy Gleason (Centers for Medicare & Medicaid Services) and Ryan Howells (CARIN Alliance, Leavitt Partners) explore the vision behind the CMS Health Tech Ecosystem and its potential to transform how health data is accessed, exchanged, and used across the healthcare system. The discussion examines the value this approach could deliver for patients, providers, and innovators, while also highlighting how industry stakeholders can help build a more connected, interoperable, and consumer-centered digital health landscape.

This week on Pulse: Hot Topics, Louise and George cover a fortnight that captured the whole spectrum of digital health in 2026 — political turmoil at the top, consumer tech-led disruption from below, and an expert call for responsible AI delivery in the middle.UK Health Secretary Resigns as Palantir Contract Unravels — Wes Streeting resigns; James Murray becomes the 9th UK Health Secretary in 8 years; the £330M NHS Federated Data Platform faces a break clause as workforce, MPs and unions revolt. Reports emerge of Palantir staff being granted "unlimited access" to identifiable patient data, while the NHS Analysts Together collective launches an open letter calling for the contract to end.The Wearable Category Just Split Three Ways — Google retires Fitbit, launches Google Health with a Gemini-powered AI Coach and the $99 Fitbit Air, cross-platform with Apple HealthKit. One day later, WHOOP launches live clinician video consultations and EHR integration via HealthEx, backed by Mayo Clinic and Abbott. Meanwhile Oura quietly acquires Galen AI to build a longitudinal health operating system. Three completely different theories of where value sits in wearable health.Responsible AI UK: The Delivery Playbook — A BMJ Digital Health editorial from RAi UK sets out four priorities for execution: infrastructure and open standards, problem-focused innovation, holistic evaluation, and workforce capability. Essentially the operating manual the new UK Health Secretary should be reading tonight.Resources:Stryker Vocera's Initial Delays Diagnosis Quiz LinkResponsible AI UK, BMJ Digital Health& AI LinkDigital Health Workforce Census (opens 1 May, ANZ) LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Ireland's growing reputation as a global leader in digital healthtech innovation was highlighted at a major industry event which took place at Trinity Business School. Scaling Digital Healthtech in Ireland, hosted by the four Irish European Digital Innovation Hubs (EDIH),in collaboration with Enterprise Europe Network and Ibec, saw over 400 stakeholders from across the health and life sciences sector come together to hear from leading experts across government, industry and academia, alongside panel discussions and case studies showcasing real-world innovation and impact. Digital Healthtech represents the combination of smart connected devices and AI-powered digital health tools which are transforming the delivery of healthcare and creating opportunities for new disruptive products and services by Irish companies. The event marks the first in a series of national engagements designed to support Irish SMEs and public sector organisations in accelerating the development and adoption of digitisation and to increase the awareness of supports which are already available. Ireland has established itself as a hub for cutting-edge healthtech innovation, supported by a thriving ecosystem of technology companies, researchers and policymakers. The event explored both the opportunities and challenges associated with scaling digital healthtech solutions, including artificial intelligence integration, regulatory compliance, cyber resilience, and access to funding and European markets. Speaking at the event, Minister of State for Trade Promotion, Artificial Intelligence and Digital Transformation Niamh Smyth TD underlined the Government's commitment to advancing Ireland's digital health ecosystem. "Today highlights the strength of Ireland's digital transformation and its growing, innovative healthtech ecosystem. The Government recognises the importance of maintaining and building on this momentum. At the end of 2025, €23 million was announced through my Department and the Digital Europe Programme to extend the European Digital Innovation Hubs (EDIH) Programme to 2029. This investment will enable our hubs to significantly accelerate digitalisation among SMEs and public sector organisations, delivering over 3,000 engagements, 1,100 "Test Before Invest" projects, and more than 200 training courses nationwide. "As work progresses on the National Life Sciences Strategy, Ireland is well positioned to lead the future development of this sector. Bringing together industry, innovation, and expertise is essential to achieving our shared ambition: supporting Irish companies to scale globally while delivering meaningful benefits for patients and healthcare systems. "These efforts are reinforced by a wide range of supports designed to help SMEs grow and internationalise their digital health solutions. These include Enterprise Ireland, the National Enterprise Hub, Local Enterprise Offices, Ibec, Health Innovation Hub Ireland, the European Enterprise Network, and the network of European Digital Innovation Hubs operating across Ireland." Joe Healy, Head of Research and Innovation at Enterprise Ireland said: "Through the European Digital Innovation Hubs, we are supporting Irish enterprises of all sizes and stages to harness advanced technologies, build capability, and compete internationally. This event demonstrates the importance of connecting the network to drive uptake of the supports on offer and strengthening collaboration across industry, government and academia." Ciara Finlay, Ibec Senior Executive said, "Demographic shifts accompanied by the rise of chronic diseases, coupled with the recent impact of the greatest global health emergency in over a century have highlighted the importance of fostering better health system resilience across the world. Digital Health is a solution that can unlock some of the challenges ahead. The digital health segment is estimated to grow at over 17.4% between 2021 and 2027 to €426 billion. "The Medtech, digital health...

Episode 77 - Sam Fay, CEO of SISU Health, is leading the mission to make preventative health more accessible. With 25 years' leadership experience, she has a proven track record in scaling organisations and driving measurable impact.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Ron Books on Human-First AI & Arizona Becoming a Health Tech Hub Ron Books, CEO of Net Health, talks about how he believes that AI is the only thing that can save the human element in healthcare, examples from the wound care and rehab therapy spaces, and how Arizona is becoming a health tech hub.  All that, plus the Flava of the Week about the CMS Health Tech Ecosystem's First Wave event. How significant was it to see demos from more than 50 companies that are making good on their pledge to create a fully digital, patient-centered health system, and what's your part in helping consumers understand and trust what's possible now? Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI in healthcare may be entering a new chapter, one where the biggest question is no longer whether the technology works, but who is willing to deploy it, measure it, and take responsibility for the risk.This week, Steve sits down again with Eric Larsen to revisit his predictions from last year's Webby-winning episode on generative AI in healthcare. Eric argues that the first wave of AI has been inflationary, reinforcing the old payer-provider payment model, but that the next wave could be deflationary as automation moves into revenue cycle, administrative work, clinical reasoning, and drug development. They discuss why incumbents still have a narrow window to co-develop the future, why clinical AI may move faster outside the US, and why liability may become the deciding factor in who wins.We cover:Why healthcare is still the sector most exposed to AI-driven changeHow AI has reinforced fee-for-service dynamics so far, and why that may soon reverseWhat makes some healthcare work more automatable than othersWhy liability may determine how fast clinical AI gets adoptedWhich health systems, payers, and life sciences companies are moving fastestWhat will change across providers, payers, and pharma over the next year—

What does the senior CMS official focused on payment and delivery innovation actually want health tech founders to understand? In this episode, we listen in on highlights from a recent fireside chat as StartUp Health co-founder Unity Stoakes talks with...

In this episode of Medsider Radio, we sat down with Antony Odell, co-founder and CEO of Echopoint Medical.Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics.Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tissue Regenix. He holds a BSc in Physiology and Biochemistry.In this interview, Antony discusses translating academic IP into a commercial device, choosing early clinical sites to balance speed and learning, managing non-dilutive funding as a long-term discipline, and outlines the most important responsibilities of an early-stage medtech CEO.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Antony Odell, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:06) - How Antony's career centered on translating clinical insights into commercial reality (05:54) - What Echopoint's iKOr does, and why 40% of cath lab patients leave without a diagnosis (12:13) - How Echopoint landed its first U.S. clinical site, and what that means for the company (13:48) - What to assess before spinning out an academic idea, and why clinician input is the first real test (20:14) - Why Echopoint chose Barts over typical sites for its first-in-human study (22:58) - How getting too close to one clinical site can lead to dangerous groupthink (30:54) - Why non-dilutive funding belongs on the board agenda permanently (39:54) - How CEOs should manage boards, control information flow, and avoid becoming a “glorified note-taker”

This episode is the final installment in a three-part miniseries on ABM and go-to-market strategy, and it is extremely practical. My guest is Rehan Mirza, Chief Growth Officer at Verifiable, a credentialing automation platform that has lived through every stage of the ABM journey, from cold outbound blasting to sophisticated, intent-driven orchestration across a complex enterprise sales motion.Rehan tells the story of how Verifiable evolved its ICP from fast-moving digital health startups to regional health plans with hundreds of thousands of providers, and why that shift forced a complete rethink of how marketing, BDR, and alliances teams operate together. He talks candidly about the early lesson that volume-based outbound erodes trust, especially in healthcare, and how that shaped a completely different philosophy built around delivering value before making an ask.If you are a healthcare technology marketer working through how to make ABM actually function inside your organization, this episode gives you a clear, honest view of what it takes. Rehan has the scars to prove it.Key Topics: "(00:00:00)" Introduction and the Sway Health Podcast of the Year Award"(00:03:00)" Bridging the gap between AI activity and revenue results"(00:05:00)" Defining credentialing and Verifiable's origin story"(00:07:00)" Transitioning from a free proof of concept to a Salesforce-integrated platform"(00:09:00)" Shifting from cold outbound to intent-based lead orchestration"(00:10:00)" Ideal Customer Profile (ICP) evolution: From digital health to major payers"(00:14:00)" Moving up-market and the role of hyper-focus in ABM"(00:15:00)" Rethinking attribution: Why 70 to 80 percent overlap is the goal"(00:18:00)" Moving from pipeline generation to pipeline acceleration"(00:22:00)" The CORE framework: Conversion, Orchestration, Resonance, and Ecosystems"(00:23:00)" Using AI SDRs as a channel rather than a replacement for humans"(00:25:00)" Lessons learned: Why volume-based "spamming" erodes trust in healthcare"(00:28:00)" Closing summary and key takeaways for ABM successIf you are interested in discussing this or any other topic, let's have a chat.  Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.Follow me on LinkedIn.Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.

Betsy Kauffman is a globally recognized executive leadership coach and organizational agility consultant with over 25 years of experience transforming Fortune 500 leadership teams into high-performing, aligned powerhouses. As Founder and CEO of Cross Impact Coaching, she partners with CEOs and their executive teams—primarily in HealthTech and FinTech—to align strategy, execution, and team dynamics for lasting results. Her signature Leadership Alignment Lab blends executive coaching, proprietary 360 feedback, and strategic offsites to help C-suites turn vision into action. She also co-owns Kauffman & Co. Furniture, giving her a unique perspective on scaling and leading both service- and product-based businesses.      

How to Connect Marketing to Revenue On this episode host Adam Turinas is joined by two guests who have done the real work of building a model that clearly connects marketing to revenue. First, Paula Cobb, VP of Marketing at AvaSure, a private equity-backed virtual care platform. Paula brings over 30 years of healthcare marketing experience and runs what she calls a peanut butter and jelly go-to-market model, where sales, marketing, and customer success are genuinely inseparable. What he find compelling about her perspective is how tightly she has wired marketing into product decisions and the fact that AI tools have essentially become named members of her org chart. His second guest is Alex Esquivel, VP of Marketing at Luma Health. Alex has an unusual background for a marketer. She came up through finance and operations, which gives her an unusually clear-eyed view of why the traditional MQL model was, in her words, doomed from the start. She describes what a genuinely revenue-accountable marketing model looks like in practice, including how she structures account-based motions, why she does not measure MQLs at all, and how she is moving from slow campaign cycles to fast, iterative content that responds to what buyers actually care about. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Medsider Radio, we sat down with Kurt Jacobus, co-founder and CEO of restor3d.restor3d provides patient-specific orthopedic implants using 3D printing and advanced software.Kurt has over two decades of experience in medtech entrepreneurship, including successful exits to Enovis and NuVasive. Prior to his career in medical devices, Kurt was a consultant at McKinsey & Company. He holds a PhD in Mechanical Engineering and is an Adjunct Professor at Georgia Tech. In this interview, Kurt discusses how restor3d used the FDA's 520(b) pathway to generate revenue and regulatory proof simultaneously, why self-regulating beyond FDA requirements makes submissions a competitive barrier, and how to approach investor relationships and board construction with long-term thinking.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kurt Jacobus.KEY MOMENTS FROM THE INTERVIEW(03:21) - How Kurt went from wanting to build race cars to 20 years of orthopedic entrepreneurship (06:03) - How restor3d's patient-specific implants challenge the “8 sizes fit 8 billion people” model (15:36) - Why early-stage companies should “ring the cash register” as soon as possible (17:16) - How a 520(b) pathway helped restor3d generate revenue before full FDA clearance (31:48) - How restor3d treats every FDA submission like a PhD thesis and holds itself to standards beyond what regulators ask for (35:24) - What Kurt learned from restor3d's limited market release (40:03) - How Kurt raised is last$100M+ round, and why fundraising is really a networking game (45:13) - What makes a great board, and how the wrong one can quietly derail a company

Medicaid reimbursements are shrinking, providers are pulling back, and vulnerable populations are losing access to care. Akido Labs is betting that AI can expand care capacity fast enough to reverse that trend.This week, Halle sits down with Prashant Samant, co-founder and CEO of Akido Labs, to discuss what it actually takes to scale care with AI. They explore why Akido built a full-stack healthcare company, how its AI operates inside real clinical workflows, and why the hardest patients are the best place to test whether this model works.We cover:Why he chose to build a full-stack care modelHow AI changes who can deliver care, and whereWhy most healthcare AI tools fail once they hit real clinical workflowsWhy the doctor shortage cannot be solved by training more doctorsHow the bottleneck in healthcare AI is absorption, not innovationAbout our guest:Prashant S. Samant is CEO and co-founder of Akido, a healthcare technology company that builds clinical AI and operates a multi-state medical network serving hundreds of thousands of patients. He co-founded Akido in 2015 through USC's Digital Health Lab. In 2023, he and his co-founders received the EY Entrepreneur of the Year–Greater Los Angeles Award. Samant is also a co-founder and board member of Grid110, a nonprofit accelerator supporting early-stage entrepreneurs. He holds a bachelor's degree in economics from Washington University in St. Louis.— Show Notes:Akido's recently-published white paper on street medicine—

How Sales Leaders Cracked the ABM Code On this episode instead of talking to marketers about account-based marketing, host Adam Turinas sat down with two sales leaders who have built and executed ABM programs from the ground up. They bring sharp, practical views on what it actually takes to make ABM work. His guests are Clint Mooneyham, VP of Sales at Sagility, a healthcare operations company serving payers and providers, and Tony Mancuso, an enterprise sales leader on the growth team at Onymos, a Series A AI startup focused on diagnostic labs and precision medicine. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Rachel Stauffer and Lisa Mazur join Julia Grabo to discuss key takeaways from the 2026 Health Tech Investment Forum and what they are watching for next in the health tech space.

Episode 76 - Rachel Murphy, founder of The Grafter, is a trusted UK operator known for building real business value. She has grown, scaled and sold multiple companies, including her second, Difrent, in a major eight-figure deal.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

AI is everywhere in healthcare, and May's big question is whether it's actually delivering. The money is flowing, the promises are bold, but some cracks are starting to show.Steve and Michael break down the month's biggest stories.We cover:Digital health hitting its strongest funding quarter since the pandemic peak, and why deal concentration tells the real storyHow Medvi built a billion-dollar GLP-1 company on fake doctor profiles, fake reviews, and a drug with zero bioavailabilityWhy AI in prior authorization and billing may be inflating healthcare costs rather than cutting themThe peptide craze: what the science says, what regulators have banned, and why Michael is actually taking oneHow AI could collapse today's narrow medical specialties into a "generalist specialist" modelNew research showing Epic's out-of-the-box AI models fall short on real-world clinical benchmarks—Show notes:Rock Health Q1 2026 Funding ReportNYT Profile of Medvi + Futurism InvestigationPeterson Health Technology Institute: Administrative AI ReportSTAT News / Undark: BPC-157 and the Peptide CrazeHealth Affairs Scholar: Kocher & Wachter on the Generalist-Specialist ModelSpringer Nature / Journal of General Internal Medicine: Epic AI Model Meta-Analysis—

Recorded 3/3/26Vincent's Slava Rubin and Sacra's Jan-Erik Asplund take an in-depth look at the Healthtech sector, and key startups Oura, Abridge, and Open Evidence, as well as OpenAI's impact on the industry.

In this episode of Medsider Radio, we sat down with Alfred Griffin, co-founder and CEO of LightForce.LightForce is the developer of the world's first fully customized 3D-printed bracket system directly personalized for each patient's digital treatment plan.Alfred holds a DMD and PhD in Craniofacial Biology from the Medical University of South Carolina and completed his orthodontic residency at Harvard School of Dental Medicine, where he currently serves as faculty and the Board of Fellows. An ABO-certified practicing orthodontist, he continues to see patients every month while running the company.In this interview, Alfred shares how applying existing technology to an overlooked market can unlock a larger opportunity, how adoption friction is a design problem, and why scaling a new category requires treating operations as a core product investment.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Alfred Griffin.KEY MOMENTS FROM THE INTERVIEW(02:43) - How growing up in a family of dentists shaped Alfred's path into orthodontics (07:41) - How LightForce uses digital planning and 3D printing to create fully customized braces (08:48) - Why LightForce isn't a brilliant idea, but an obvious fix for the teen braces market that aligners missed (12:19) - How LightForce is like Google Maps for teeth, eliminating detours and removing inefficiencies (17:30) - How Alfred built LightForce around his clinical strengths and hired for experience to round out the gaps (30:56) - The 3-part secret to LightForce adoption by physicians (36:42) - How Alfred approaches fundraising, matching investors to the company's stage and needs (41:51) - About LightForce's digital factories and why they're the company's core moat

Over the last six months, Health Launchpad has seen inbound meetings grow by 89% year over year, direct and referral traffic increase by 3.6x, and session engagement run 35% longer from AI-sourced visitors. Perhaps most telling, prospects are regularly showing up to first calls already familiar with who they are and what they do, because they were found through ChatGPT or Claude, not through Google or any outbound campaign. On this episode, host Adam Turinas sits down with Mark Erwich, our Chief Strategy Officer, to walk through exactly how we got here and what you can do to see similar results. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Forty million people use ChatGPT for health-related questions every day, making it one of the most widely used tools for health information in the world. So what is their team doing to maximize impact and minimize harm? For one, they've brought in hundreds of physicians globally to continuously review outputs and shape how the models respond across different scenarios, literacy levels, and edge cases. Second, they've hired my Rock Health co-founder, Nate Gross, MD, as their VP of Health.In this full-circle episode, I sit down with Nate, who also co-founded Doximity (DOCS) and knows a thing or two about building in digital health. We discuss the astonishing speed of AI progress, how models are trained for safety and accuracy, and what this technological evolution means for every part of the healthcare system.Key topics:How ChatGPT is becoming a 24/7 front door for health questions, and whether it is replacing Dr. Google or starting to compete with the healthcare system itselfHow OpenAI is trying to reduce hallucinations, avoid sycophantic behavior, and build guardrails for sensitive use cases like mental healthOpenAI's goals to “raise the floor, sweep the floor, and raise the ceiling” with new product launches like ChatGPT for Clinicians and GPT-RosalindHow Nate thinks about the AI race and what winning in healthcare actually requiresWhere startups should focus their efforts now that specialized products are launching for clinicians and life sciencesThe single hardest problem in healthcare that AI, according to Nate, probably won't fix anytime soon— About our guest:Dr. Nate Gross is the VP of Health at OpenAI. He previously co-founded Doximity and Rock Health. He graduated from the Emory University School of Medicine with an MD, Harvard Business School with an MBA, and Claremont McKenna College with a BA in Government. He serves as affiliated faculty for the Clinical Informatics Fellowship at Stanford.— Show notes:ChatGPT for CliniciansChatGPT for Health (for patients)OpenAI for HealthcareGPT-Rosalind—